La Barre Michael J. Insider Trades

Insider Trading History

Track insider trading activity for La Barre Michael J.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, Chief Technical Officer
Holding Value $12.6M 176,187 shares
Last Trade
Feb 22, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$66.5k 3,044 shares
$21.83
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, Chief Technical Officer
Holding Value $630k 8,803 shares
Last Trade
Feb 22, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$192k 8,803 shares
$21.83
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, Chief Technical Officer
Holding Value $12.8M 179,231 shares
Last Trade
Feb 22, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$192k 8,803 shares
$21.83
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, Chief Technical Officer
Holding Value $12.3M 172,423 shares
Last Trade
Feb 14, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$122k 5,772 shares
$21.10
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, Chief Technical Officer
Holding Value $12.2M 170,428 shares
Last Trade
Feb 14, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$42.1k 1,995 shares
$21.10
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, Chief Technical Officer
Holding Value $826k 11,542 shares
Last Trade
Feb 14, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$122k 5,772 shares
$21.10
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, Chief Technical Officer
Holding Value $0 0 shares
Last Trade
Feb 12, 2020 Sale
$631k 31,532 shares
$20.00
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, Chief Technical Officer
Holding Value $12.1M 169,376 shares
Last Trade
Feb 12, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$158k 7,883 shares
$20.00
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, Chief Technical Officer
Holding Value $11.9M 166,651 shares
Last Trade
Feb 12, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$54.5k 2,725 shares
$20.00
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, Chief Technical Officer
Holding Value $1.69M 23,649 shares
Last Trade
Feb 12, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$158k 7,883 shares
$20.00
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, Chief Technical Officer
Holding Value $0 0 shares
Last Trade
Feb 12, 2020 Sale
$1.2M 60,146 shares
$20.00
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, Chief Technical Officer
Holding Value $2.33M 32,533 shares
Last Trade
Feb 10, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$650k 32,533 shares
$19.98
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, Chief Technical Officer
Holding Value $4.95M 69,174 shares
Last Trade
Feb 10, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.38M 69,174 shares
$19.98
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, Chief Technical Officer
Holding Value $11.9M 165,782 shares
Last Trade
Feb 03, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$222k 11,559 shares
$19.21
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, Chief Technical Officer
Holding Value $11.6M 161,493 shares
Last Trade
Feb 03, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$82.4k 4,289 shares
$19.21
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, Chief Technical Officer
Holding Value $0 0 shares
Last Trade
Feb 03, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$222k 11,559 shares
$19.21
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, Chief Technical Officer
Holding Value $0 0 shares
Last Trade
Jul 02, 2019 Sale
$33.6k 2,000 shares
$16.78
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, Chief Technical Officer
Holding Value $0 0 shares
Last Trade
Feb 14, 2019 Sale
$670k 40,489 shares
$16.54
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, Chief Technical Officer
Holding Value $0 0 shares
Last Trade
Feb 22, 2018 Sale
$1.09M 56,352 shares
$19.28
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, Chief Technical Officer
Holding Value $0 0 shares
Last Trade
Feb 03, 2017 Sale
$962k 78,452 shares
$12.26
$71.60

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up